Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Gelderblom

Showing results (31-40 of 488) with videos related to

Pageof 49
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[A man with blisters on hand and feet]A J Hans Gelderblom, Jasper I van der Rhee, Jan Ouwerkerk
Scientific Reports|June 20, 2022
Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancersAnne Dirkson, Suzan Verberne, Wessel Kraaij, et al.
European Radiology|December 25, 2009
RECIST revised: implications for the radiologist. A review article on the modified RECIST guidelineEls L van Persijn van Meerten, Hans Gelderblom, Johan L Bloem
The Oncologist|July 14, 2023
Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II StudyAstrid Lipplaa, Willem H Schreuder, Sarina E C Pichardo, et al.
Anti-Cancer Drugs|June 5, 2003
Distribution of paclitaxel in plasma and cerebrospinal fluidHans Gelderblom, Sharyn D Baker, Ming Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
SNPs and haplotypes in DPYD and outcome of capecitabine--LetterFrans L Opdam, Jesse J Swen, Judith A M Wessels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2013
Tales of how great drugs were brought down by a flawed rationale--letterMichel D Wissing, Michael A Carducci, Hans Gelderblom, et al.
Expert Review of Molecular Diagnostics|February 4, 2016
A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic reviewMeta H M Diekstra, Jesse J Swen, Hans Gelderblom, et al.
Current Opinion in Oncology|June 17, 2020
Current concepts in the treatment of giant cell tumour of boneLizz van der Heijden, Sander Dijkstra, Michiel van de Sande, et al.
Sarcoma|May 18, 2017
Evaluation of Quality of Life at Progression in Patients with Soft Tissue SarcomaStacie Hudgens, Anna Forsythe, Ilias Kontoudis, et al.
Pageof 49

Showing results (31-40 of 488) with videos related to

Sort By:
Pageof 49
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[A man with blisters on hand and feet]A J Hans Gelderblom, Jasper I van der Rhee, Jan Ouwerkerk
Scientific Reports|June 20, 2022
Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancersAnne Dirkson, Suzan Verberne, Wessel Kraaij, et al.
European Radiology|December 25, 2009
RECIST revised: implications for the radiologist. A review article on the modified RECIST guidelineEls L van Persijn van Meerten, Hans Gelderblom, Johan L Bloem
The Oncologist|July 14, 2023
Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II StudyAstrid Lipplaa, Willem H Schreuder, Sarina E C Pichardo, et al.
Anti-Cancer Drugs|June 5, 2003
Distribution of paclitaxel in plasma and cerebrospinal fluidHans Gelderblom, Sharyn D Baker, Ming Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
SNPs and haplotypes in DPYD and outcome of capecitabine--LetterFrans L Opdam, Jesse J Swen, Judith A M Wessels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2013
Tales of how great drugs were brought down by a flawed rationale--letterMichel D Wissing, Michael A Carducci, Hans Gelderblom, et al.
Expert Review of Molecular Diagnostics|February 4, 2016
A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic reviewMeta H M Diekstra, Jesse J Swen, Hans Gelderblom, et al.
Current Opinion in Oncology|June 17, 2020
Current concepts in the treatment of giant cell tumour of boneLizz van der Heijden, Sander Dijkstra, Michiel van de Sande, et al.
Sarcoma|May 18, 2017
Evaluation of Quality of Life at Progression in Patients with Soft Tissue SarcomaStacie Hudgens, Anna Forsythe, Ilias Kontoudis, et al.
Pageof 49